Triple
T13942296
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pfizer–BioNTech |
E335285
|
entity |
| Predicate | productBrandName |
P40804
|
FINISHED |
| Object |
Comirnaty
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
|
E1075482
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Comirnaty | Statement: [Pfizer–BioNTech, productBrandName, Comirnaty]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Comirnaty Context triple: [Pfizer–BioNTech, productBrandName, Comirnaty]
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
C.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
D.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
E.
mRNA-1273
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Comirnaty Triple: [Pfizer–BioNTech, productBrandName, Comirnaty]
Generated description
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Comirnaty Target entity description: Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
C.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
D.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
E.
mRNA-1273
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: productBrandName Context triple: [Pfizer–BioNTech, productBrandName, Comirnaty]
-
A.
hasBrandName
chosen
Indicates that an entity is associated with or identified by a specific brand name.
-
B.
parentBrand
Indicates that one brand is the overarching or owning brand from which another brand is derived or subordinated.
-
C.
usedBrand
Indicates that an entity has utilized, applied, or operated a particular brand in some context.
-
D.
usedBrandOf
Indicates that one entity made use of or operated an item, product, or service associated with a particular brand.
-
E.
nicknameOfProduct
Indicates that one term is used as an informal or alternative name (nickname) for a particular product.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c6081b88190b53e317c3370c8fe |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e0f6f3c8190a64058b732b0ac52 |
completed | April 14, 2026, 12:07 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fbc3201af48190a1746abbf080187d |
completed | May 6, 2026, 10:39 p.m. |
| NEDg | Description generation | batch_69fbc62b8b308190bbf13f8536bf4449 |
completed | May 6, 2026, 10:52 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69fbc6b13f0481908ba6ff97421c8506 |
completed | May 6, 2026, 10:54 p.m. |
| PD | Predicate disambiguation | batch_69de05a3ccf88190b45c742db483fa08 |
completed | April 14, 2026, 9:15 a.m. |
Created at: April 9, 2026, 10:17 p.m.